Management of ADHD in children across Europe: patient demographics, physician characteristics and treatment patterns
Open accessAbstract
This study was a retrospective chart review performed to examine and describe physician practice patterns in managing attention deficit/hyperactivity disorder (ADHD) across Europe. Physicians treating ADHD in the UK, France, Germany, Italy, the Netherlands and Spain were recruited. Each physician abstracted medical records of five patients (aged 6-17 years at time of review) with a documented diagnosis of ADHD made between January 2004 and June 2007. Data provided by the physician via the abstraction included (a) physician characteristics, (b) patient characteristics, (c) ADHD diagnosis and (d) ADHD outcomes (adherence, symptom control and satisfaction). A total of 779 patients met study inclusion criteria. In the overall population, patients' mean (SD) age at time of diagnosis was 8.9 (2.6) years. The predominant treatment choice was long-acting methylphenidate, which was prescribed to more than 56 % of patients. According to physicians, only 30.8 % of patients showed 'complete symptom control' on current treatment and only 31.8 % of physicians reported being 'very satisfied' with their patients' current treatment. Physicians' assessments of complete symptom control and physician satisfaction with treatment were low, indicating unmet needs with current ADHD management in Europe.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The prevalence of sleep disturbances in individuals with ADHD is reported to be in the range 25-55%.
“the prevalence of sleep disturbances in individuals with ADHD is reported to be in the range 25–55 % (Corkum et al. 1998; Hodgkins et al. 2013; Owens 2005; Sung et al. 2008).”
From Associations of sleep disturbance with ADHD: implications for treatment (2015) · cites this paper as Hodgkins et al. 2013
ADHD is commonly associated with disordered or disturbed sleep.
“Attention-deficit/hyperactivity disorder (ADHD) is commonly associated with disordered or disturbed sleep.”
From Associations of sleep disturbance with ADHD: implications for treatment (2015) · cites this paper as Hodgkins et al. 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346 · see citing works
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765 · see citing works
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.564 · Cited by 1,738 · see citing works
Johnston, C., & Mash, E. J. (2001) · Clinical Child and Family Psychology Review · doi:10.1023/a:1017592030434 · Cited by 1,165 · see citing works
Harpin, V. A. (2005) · Archives of Disease in Childhood · doi:10.1136/adc.2004.059006 · Cited by 789 · see citing works
Self-citationA Prospective 4-Year Follow-up Study of Attention-Deficit Hyperactivity and Related Disorders
Biederman, J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050073012 · Cited by 768 · see citing works
European clinical guidelines for hyperkinetic disorder ? first upgrade
Taylor, E., D�pfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Rothenberger, A., Sonuga-Barke, E., et al. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-1002-x · Cited by 682 · see citing works
Attention-Deficit/Hyperactivity Disorder: Diagnosis, Lifespan, Comorbidities, and Neurobiology
Spencer, T. J., Biederman, J., & Mick, E. (2007) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsm005 · Cited by 634 · see citing works
PLISZKA, S. R., CRISMON, M. L., HUGHES, C. W., CORNERS, C. K., EMSLIE, G. J., JENSEN, P. S., McCRACKEN, J. T., SWANSON, J. M., & LOPEZ, M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000215326.51175.eb · Cited by 442 · see citing works
Biederman, J., Krishnan, S., Zhang, Y., McGough, J. J., & Findling, R. L. (2007) · Clinical Therapeutics · doi:10.1016/s0149-2918(07)80083-x · Cited by 404 · see citing works
Long-term prognosis in attention-deficit/hyperactivity disorder.
Mannuzza, S., & Klein, R. (2000) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30114-7 · Cited by 395 · see citing works
Sallee, F. R., Mcgough, J., Wigal, T., Donahue, J., Lyne, A., & Biederman, J. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318191769e · Cited by 391 · see citing works
Attention-deficit/hyperactivity disorder: a life-span perspective.
Biederman, J. (1998) · PubMed · Cited by 361 · see citing works
Biederman, J., Melmed, R. D., Patel, A., McBurnett, K., Konow, J., Lyne, A., Scherer, N., & for the SPD503 Study Group (2008) · Pediatrics · doi:10.1542/peds.2006-3695 · Cited by 317 · see citing works
Becker, A., Hagenberg, N., Roessner, V., Woerner, W., & Rothenberger, A. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-2004-4 · Cited by 269 · see citing works
Attention-deficit/hyperactivity disorder: increased costs for patients and their families
SWENSEN, A. R., BIRNBAUM, H. G., SECNIK, K., MARYNCHENKO, M., GREENBERG, P., & CLAXTON, A. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200312000-00008 · Cited by 189 · see citing works
Rizzo, J. A., & Robert Simons, W. (1997) · Clinical Therapeutics · doi:10.1016/s0149-2918(97)80018-5 · Cited by 174 · see citing works
Jain, R., Segal, S., Kollins, S. H., & Khayrallah, M. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.11.005 · Cited by 142 · see citing works
Clonidine for Attention-Deficit/Hyperactivity Disorder: I. Efficacy and Tolerability Outcomes
Palumbo, D. R., Sallee, F. R., Pelham, W. E., Bukstein, O. G., Daviss, W. B., & McDermott, M. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815d9af7 · Cited by 140 · see citing works
Why Do Children With ADHD Discontinue Their Medication?
Toomey, S. L., Sox, C. M., Rusinak, D., & Finkelstein, J. A. (2012) · Clinical Pediatrics · doi:10.1177/0009922812446744 · Cited by 118 · see citing works
The Hyperactive Child in Elementary School: A 5 Year, Controlled, Followup
MINDE, K. K., Lewin, D., Weiss, G., Lavigueur, H., Douglas, V. I., & Sykes, E. (1971) · Exceptional Children · doi:10.1177/001440297103800304 · Cited by 113 · see citing works
the 311 Study Group, Wigal, S. B., Kollins, S. H., Childress, A. C., & Squires, L. (2009) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-3-17 · Cited by 112 · see citing works
Coghill, D. (2010) · CNS Drugs · doi:10.2165/11537450-000000000-00000 · Cited by 103 · see citing works
ADHD medication use, adherence, persistence and cost among Texas Medicaid children
Barner, J. C., Khoza, S., & Oladapo, A. O. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.603303 · Cited by 82 · see citing works
Disorders usually first diagnosed in infancy, childhood, or adolescence.
Popper, C. W., Gammon, G. D., West, S. A., & Bailey, C. E. (1994) · Cited by 69 · see citing works
The Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients
ADESMAN, A. R. (2001) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v03n0204 · Cited by 51 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Associations of sleep disturbance with ADHD: implications for treatment
Hvolby, A. (2015) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-014-0151-0 · Cited by 339 · see citing works
Sleep disturbances in adolescents with ADHD: A systematic review and framework for future research
Lunsford-Avery, J. R., Krystal, A. D., & Kollins, S. H. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.10.004 · Cited by 131 · see citing works
- Authors
- Hodgkins, P., Setyawan, J., Mitra, D., Davis, K., Quintero, J., Fridman, M., Shaw, M., & Harpin, V.
- Affiliations
- Takeda (United States) (US)
- RTI Health Solutions (US)
- Hospital Universitario Infanta Leonor (ES)
- Norgine (United Kingdom) (GB)
- Corresponding author
- Hodgkins, Paul
- Venue
- European Journal of Pediatrics
- Published
- 2013-02-26
- Volume
- 172
- Issue
- 7
- Pages
- 895-906
- ISSN
- 0340-6199 (ISSN-L)
- 1432-1076
- PMC
- PMC3701791
- OpenAlex
- W2023351650
- Cited by
- 92
- References
- 26
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 5 · 2023: 9 · 2022: 5 · 2021: 10 · 2020: 6 · 2019: 6 · 2018: 10 · 2017: 4 · 2016: 10 · 2015: 3 · 2014: 7 · 2013: 6
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- European Journal of Pediatrics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Keywords
- attention deficit hyperactivity disorder, children, methylphenidate, long-acting stimulants, symptom management, medication adherence, physician satisfaction, physician characteristics, patient demographics, Europe
- MeSH terms
- Assessment of Medication Adherence, Adolescent, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Behavior Therapy, Child, Child, Preschool, Europe, Female, Humans, Male, Methylphenidate, Practice Patterns, Physicians', Psychiatric Status Rating Scales, Surveys and Questionnaires, Retrospective Studies, Treatment Outcome, Drug Monitoring, Medication Adherence, Symptom Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
